Semler (SMLR) awaits FDA clearance for their cardiovascular diagnostic product and boasts a cash-heavy asset base. See why SMLR stock is recommended a buy.
Original Image Link
Source:seekingalpha.com
Original Image Link
Source:seekingalpha.com
Posted: 2024-04-30 06:00:00